Sabre (SABR): Constellation’s most asymmetric bet
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
@yenoms One of us! One of us!! $VNO Pref Gang
Continued insider buying from the Chairman of $ALTO ...
Dear $AMC Apes. Your favorite stock is cheaper than last week. Maybe it is time to buy more.
Adient has $435 million of buyback capacity, equal to 38% of its market value, after adding $400 million to its repurchase program.
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
Dave & Buster’s faces fourteen straight quarters of same-store sales declines, shrinking margins and a new CEO’s turnaround plan after…
Chord Energy trades at 3x mid-cycle EV/EBITDA with a 15% free-cash-flow yield at $75 WTI, while repurchasing shares and expanding its…
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
Perpetua Resources’ permitted Stibnite project holds 4.8 million gold ounces and a $2.9 billion EXIM loan, but faces single-asset…
BKV · long BKV Corp, public for less than two years, is an underfollowed natural-gas producer pursuing early-stage projects and a transition.
Carl Icahn joins CNBC by phone after Bill Ackman closes his Herbalife short position.
Carl Icahn speaks by phone with Fox Business about Mylan, Apple, economic growth and his Herbalife stake.
Charlie Munger answers shareholder questions at the Daily Journal meeting, returning to the company’s court-software expansion and the…
Carl Icahn discusses activist investing at the 2015 DealBook Conference, arguing that long holding periods and operational changes can…
Bill Ackman presents Pershing Square’s short case against Herbalife at a Sohn Conference event.
Bill Ackman opens a Pershing Square webcast with a film featuring former Herbalife distributors, followed by a panel moderated by MLM…
Bill Ackman discusses Pershing Square’s campaign at JCPenney after his resignation from its board, defending Ron Johnson’s strategy while…
Bill Ackman and Carl Icahn’s 2013 CNBC clash over Herbalife preceded Icahn’s $1 billion-plus exit and Ackman’s loss on the stock.
Bill Ackman discusses his more than $1 billion short position in Herbalife in a CNN interview.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.